Brief: Lumos Pharma Reports First Quarter 2023 Financial Results, Provides Clinical Updates
03/05/2023 23:04
Lumos Pharma Inc LUMO.O :
* LUMOS PHARMA REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS,
PROVIDES CLINICAL UPDATES
* LUMOS PHARMA INC - ENDED QUARTER WITH CASH, CASH
EQUIVALENTS AND
SHORT-TERM INVESTMENTS TOTALING $58.0 MILLION COMPARED TO $67.4
MILLION ON DECEMBER 31, 2022
* LUMOS PHARMA INC - NET LOSS FOR QUARTER ENDED MARCH 31,
2023 WAS
$7.3 MILLION
* LUMOS PHARMA INC - PRIMARY OUTCOME DATA FOR BOTH ORAGROWTH
TRIALS EXPECTED 4Q 2023
Source text for Eikon: ID:nGNX9TZqpb
Further company coverage: LUMO.O
Recent news on Lumos Pharma
See all newsLumos Pharma Inc expected to post a loss of 76 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Apple, Hershey, Dow
U.S. STOCKS ON THE MOVE-Magnite, Nvidia, Tesla
Lumos Pharma climbs on $38 mln go-private deal
Brief: Lumos Pharma Enters Into Definitive Merger Agreement With Double Point Ventures To Go Private Via A Tender Offer Of $4.25 Cash Per Share Plus Contingent Value Rights (Cvr)